ATLASATLAS fair value
₩500,765
Below fair value · 54% discount
Range: ₩456,231–₩844,257Fair valuePrice
Pharma Reaserch Prod (214450.KQ)
Pharma Reaserch Prod stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · KOSDAQ · South Korea
₩229,500▼ -4.18%
Prices as of Oct 26, 2026 · KRW
Chance of rising in 1 month
47%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Pharma Reaserch Prod in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Pharma Reaserch Prod
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Pharma Reaserch Prod's fair value at about ₩500,765 per share (reasonable range: ₩456,231 to ₩844,257). At ₩229,500, the stock trades 54% below it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Pharma Reaserch Prod a 47% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₩203,469 and ₩253,239; in 9 out of 10, between ₩167,593 and ₩307,449. Estimated annual volatility is 64%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ₩2.7T
- Market cap (USD)
- $2.0B
- P/E ratio
- 14.9
- Dividend yield
- 1.33%
- 52-week high
- ₩561,000
- 52-week low
- ₩228,500
- Revenue (12 months)
- ₩604B
- Gross margin
- 77.7%
- Operating margin
- 37.2%
- Net margin
- 30.8%
- Beta
- 0.47
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Pharma Reaserch Prod sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks 214450.KQ has traded between ₩228,500 and ₩561,000. Today it is 59.1% below that high and 0% above its low.
On the business: net margin is 30.8%; it trades at 14.9 times earnings.
Its beta is 0.47: it tends to move less than the market.
About the company
PharmaResearch Co., Ltd., together with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea. ; and Rejuvenex cream, which treats the wound through rapid tissue regeneration.
Want to see everything about Pharma Reaserch Prod?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Pharma Reaserch Prod (214450.KQ) fair value?
About ₩500,765 per share according to ATLAS (reasonable range: ₩456,231 to ₩844,257). With the stock at ₩229,500, it is 54% below it.
What is the chance 214450.KQ goes up next month?
47%: close to a coin flip. In half of the simulated outcomes, 214450.KQ ends the month between ₩203,469 and ₩253,239.
How big is Pharma Reaserch Prod and what is its P/E ratio?
Pharma Reaserch Prod's market capitalization is ₩2.7T. Its price-to-earnings (P/E) ratio is 14.9: you pay ₩14.9 for each ₩1.00 of yearly earnings.
Does Pharma Reaserch Prod pay a dividend?
Yes. 214450.KQ's current dividend yield is 1.33% at today's price (₩229,500).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer